|
Re: New Frontiers for both RVX/Zenith
|
1
|
Resverlogix Corp.
|
Apr 18, 2017 11:22AM
|
|
Re: AGM attendance
|
1
|
Resverlogix Corp.
|
May 24, 2022 09:53PM
|
|
Re: Sarah's response...
|
1
|
Resverlogix Corp.
|
Apr 25, 2017 02:52PM
|
|
Re: BETonMACE top line data
|
1
|
Resverlogix Corp.
|
Jan 16, 2018 07:08PM
|
|
Re: Sarah's response...
|
1
|
Resverlogix Corp.
|
Apr 25, 2017 03:21PM
|
|
Re: AGM Comments
|
1
|
Resverlogix Corp.
|
Jun 21, 2022 04:31PM
|
|
Re: iceberg or ice cube?
|
1
|
Resverlogix Corp.
|
May 17, 2017 12:31PM
|
|
Re: Resverlogix has been shortlisted for the Buzz of Bio award "Pipelines of Promise...
|
1
|
Resverlogix Corp.
|
Apr 04, 2017 09:42AM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 22, 2020 07:25PM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 22, 2020 07:29PM
|
|
Re: Re San fran
|
1
|
Resverlogix Corp.
|
Oct 19, 2020 05:43PM
|
|
Re: Hopefully DM's exuberance is justified in the secondary endpoints
|
1
|
Zenith Epigenetics
|
Nov 18, 2019 05:09PM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 22, 2020 08:48PM
|
|
Re: Zenith
|
1
|
Resverlogix Corp.
|
Nov 21, 2019 05:48PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
1
|
Zenith Epigenetics
|
May 20, 2024 11:26PM
|
|
Re: New Frontiers for both RVX/Zenith
|
1
|
Resverlogix Corp.
|
Apr 18, 2017 04:37PM
|
|
Re: Just pathetic
|
1
|
Resverlogix Corp.
|
Sep 18, 2024 11:30PM
|
|
Re: IR response
|
1
|
Resverlogix Corp.
|
Jan 12, 2022 08:44AM
|
|
Re: NOL carry forward may be one reason Eastern did not renew loan
|
1
|
Resverlogix Corp.
|
Dec 22, 2017 08:51AM
|
|
Re: Contest Tally
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 08:39PM
|
